Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Expert Review of Vaccines|July 27, 2013
Clinical vaccine development for H5N1 influenzaChristopher H Clegg, Joseph A Rininger, Susan L Baldwin
Current Opinion in Chemical Biology|July 23, 2002
Staking out novelty on the genomic frontierKerry E Quinn-Senger, Ravi Ramachandran, Joseph A Rininger, et al.
Plos One|February 20, 2014
GLA-AF, an emulsion-free vaccine adjuvant for pandemic influenzaChristopher H Clegg, Richard Roque, Lucy A Perrone, et al.
BMC Biotechnology|November 1, 2012
Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stabilityElena Feshchenko, David G Rhodes, Rachael Felberbaum, et al.
Journal of Proteome Research|July 16, 2013
Comparative glycomics analysis of influenza Hemagglutinin (H5N1) produced in vaccine relevant cell platformsYanming An, Joseph A Rininger, Donald L Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Adjuvant solution for pandemic influenza vaccine productionChristopher H Clegg, Richard Roque, Neal Van Hoeven, et al.
Vaccine|November 11, 2008
A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cellsNathalie Bonafé, Joseph A Rininger, Richard G Chubet, et al.
Pageof 1